Bryan Supran

Director, KING PHARMACEUTICALS INC.

Companies

Alnylam PharmaceuticalsGeneral counsel Sep 22, 2025 to now¹
ViatrisBoard member Aug 6, 2020 to Nov 16, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Alnylam Pharmaceuticals ALNY14,565 shares³$3.4M at $235.58Mar 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 2, 2026Granted 1,539 shares of Alnylam Pharmaceuticals³
Oct 1, 2025Granted 13,026 shares of Alnylam Pharmaceuticals⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlnylam Pharmaceuticals, General counsel
2
SEC EDGARViatris, Board member
3
SEC EDGARAlnylam Pharmaceuticals shares after the filing of Mar 2, 2026
4
SEC EDGARForm 4 filed Oct 3, 2025